162 related articles for article (PubMed ID: 7657521)
21. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
Keren Z; Leland F; Nakajima M; LeGrue SJ
Cancer Res; 1989 Jan; 49(2):295-300. PubMed ID: 2910449
[TBL] [Abstract][Full Text] [Related]
22. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
23. Involvement of heparanase in tumor metastasis and angiogenesis.
Vlodavsky I; Michaeli RI; Bar-Ner M; Fridman R; Horowitz AT; Fuks Z; Biran S
Isr J Med Sci; 1988; 24(9-10):464-70. PubMed ID: 2462549
[TBL] [Abstract][Full Text] [Related]
24. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis.
Vlodavsky I; Fuks Z; Ishai-Michaeli R; Bashkin P; Levi E; Korner G; Bar-Shavit R; Klagsbrun M
J Cell Biochem; 1991 Feb; 45(2):167-76. PubMed ID: 1711529
[TBL] [Abstract][Full Text] [Related]
25. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.
Uno F; Fujiwara T; Takata Y; Ohtani S; Katsuda K; Takaoka M; Ohkawa T; Naomoto Y; Nakajima M; Tanaka N
Cancer Res; 2001 Nov; 61(21):7855-60. PubMed ID: 11691803
[TBL] [Abstract][Full Text] [Related]
26. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
[TBL] [Abstract][Full Text] [Related]
27. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
Tumova S; Hatch BA; Law DJ; Bame KJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
[TBL] [Abstract][Full Text] [Related]
28. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
29. Human prostate carcinoma cells produce extracellular heparanase.
Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
[TBL] [Abstract][Full Text] [Related]
30. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
32. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
[TBL] [Abstract][Full Text] [Related]
33. Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.
Sasaki M; Ito T; Kashima M; Fukui S; Izumiyama N; Watanabe A; Sano M; Fujiwara Y; Miura M
Mediators Inflamm; 2001 Oct; 10(5):259-67. PubMed ID: 11759110
[TBL] [Abstract][Full Text] [Related]
34. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin.
Han J; Woytowich AE; Mandal AK; Hiebert LM
Exp Biol Med (Maywood); 2007 Jul; 232(7):927-34. PubMed ID: 17609509
[TBL] [Abstract][Full Text] [Related]
35. A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity.
Rechter M; Lider O; Cahalon L; Baharav E; Dekel M; Seigel D; Vlodavsky I; Aingorn H; Cohen IR; Shoseyov O
Biochem Biophys Res Commun; 1999 Feb; 255(3):657-62. PubMed ID: 10049766
[TBL] [Abstract][Full Text] [Related]
36. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
37. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.
Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O
J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728
[TBL] [Abstract][Full Text] [Related]
39. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
40. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
